DE69724682T2 - Verwendung von Gonadotropin releasing Hormon Analogen oder änlichen Verbindungen zur Herstellung von pharmazeutischen Zubereitungen als Zusatz für invasiver Behandlung von Karzinomen - Google Patents

Verwendung von Gonadotropin releasing Hormon Analogen oder änlichen Verbindungen zur Herstellung von pharmazeutischen Zubereitungen als Zusatz für invasiver Behandlung von Karzinomen Download PDF

Info

Publication number
DE69724682T2
DE69724682T2 DE69724682T DE69724682T DE69724682T2 DE 69724682 T2 DE69724682 T2 DE 69724682T2 DE 69724682 T DE69724682 T DE 69724682T DE 69724682 T DE69724682 T DE 69724682T DE 69724682 T2 DE69724682 T2 DE 69724682T2
Authority
DE
Germany
Prior art keywords
releasing hormone
carcinomas
gonadotropin releasing
gonadotropin
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69724682T
Other languages
German (de)
English (en)
Other versions
DE69724682D1 (de
Inventor
Gary D. Hodgen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastern Virginia Medical School
Original Assignee
Eastern Virginia Medical School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24472058&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69724682(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eastern Virginia Medical School filed Critical Eastern Virginia Medical School
Application granted granted Critical
Publication of DE69724682D1 publication Critical patent/DE69724682D1/de
Publication of DE69724682T2 publication Critical patent/DE69724682T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE69724682T 1996-03-18 1997-03-18 Verwendung von Gonadotropin releasing Hormon Analogen oder änlichen Verbindungen zur Herstellung von pharmazeutischen Zubereitungen als Zusatz für invasiver Behandlung von Karzinomen Revoked DE69724682T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/617,048 US5691314A (en) 1996-03-18 1996-03-18 Adjunctive therapy
US617048 1996-03-18

Publications (2)

Publication Number Publication Date
DE69724682D1 DE69724682D1 (de) 2003-10-16
DE69724682T2 true DE69724682T2 (de) 2004-07-15

Family

ID=24472058

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69724682T Revoked DE69724682T2 (de) 1996-03-18 1997-03-18 Verwendung von Gonadotropin releasing Hormon Analogen oder änlichen Verbindungen zur Herstellung von pharmazeutischen Zubereitungen als Zusatz für invasiver Behandlung von Karzinomen

Country Status (7)

Country Link
US (2) US5691314A (fr)
EP (1) EP0796622B1 (fr)
AT (1) ATE249233T1 (fr)
DE (1) DE69724682T2 (fr)
DK (1) DK0796622T3 (fr)
ES (1) ES2206622T3 (fr)
PT (1) PT796622E (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780435A (en) 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
US6254601B1 (en) 1998-12-08 2001-07-03 Hysterx, Inc. Methods for occlusion of the uterine arteries
US6550482B1 (en) 2000-04-21 2003-04-22 Vascular Control Systems, Inc. Methods for non-permanent occlusion of a uterine artery
US7223279B2 (en) 2000-04-21 2007-05-29 Vascular Control Systems, Inc. Methods for minimally-invasive, non-permanent occlusion of a uterine artery
US6635065B2 (en) * 2000-11-16 2003-10-21 Vascular Control Systems, Inc. Doppler directed suture ligation device and method
US6638286B1 (en) 2000-11-16 2003-10-28 Vascular Control Systems, Inc. Doppler directed suture ligation device and method
US7354444B2 (en) 2001-03-28 2008-04-08 Vascular Control Systems, Inc. Occlusion device with deployable paddles for detection and occlusion of blood vessels
CA2442362C (fr) 2001-03-28 2009-08-11 Vascular Control Systems, Inc. Procede et appareil pour detecter et ligaturer des arteres uterines
US7207996B2 (en) 2002-04-04 2007-04-24 Vascular Control Systems, Inc. Doppler directed suturing and compression device and method
US7172603B2 (en) * 2002-11-19 2007-02-06 Vascular Control Systems, Inc. Deployable constrictor for uterine artery occlusion
US20040097961A1 (en) * 2002-11-19 2004-05-20 Vascular Control System Tenaculum for use with occlusion devices
US7404821B2 (en) 2003-01-30 2008-07-29 Vascular Control Systems, Inc. Treatment for post partum hemorrhage
US7651511B2 (en) 2003-02-05 2010-01-26 Vascular Control Systems, Inc. Vascular clamp for caesarian section
US7333844B2 (en) 2003-03-28 2008-02-19 Vascular Control Systems, Inc. Uterine tissue monitoring device and method
US7325546B2 (en) * 2003-11-20 2008-02-05 Vascular Control Systems, Inc. Uterine artery occlusion device with cervical receptacle
US7686817B2 (en) 2003-11-25 2010-03-30 Vascular Control Systems, Inc. Occlusion device for asymmetrical uterine artery anatomy
US20060015144A1 (en) * 2004-07-19 2006-01-19 Vascular Control Systems, Inc. Uterine artery occlusion staple
US7875036B2 (en) 2004-10-27 2011-01-25 Vascular Control Systems, Inc. Short term treatment for uterine disorder
JP5385282B2 (ja) * 2007-09-11 2014-01-08 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 治療剤としての血小板フィブリノーゲン受容体ヘキサペプチドアンタゴニストおよびα−エンドルフィンの使用
CA2698768A1 (fr) * 2007-09-11 2009-04-02 Dorian Bevec Utilisation d'un peptide en tant qu'agent therapeutique
CN101555274B (zh) * 2009-05-15 2013-08-21 海南双成药业股份有限公司 一种多肽固相合成比法卢定粗品的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116818A (en) * 1987-03-10 1992-05-26 Medical College Of Hampton Roads Method and kit for contraception with GnRH-antagonist
EP0477499B1 (fr) * 1990-08-04 1994-01-26 Hoechst Aktiengesellschaft Antagonistes de gonadolibérine
US5780435A (en) 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists

Also Published As

Publication number Publication date
PT796622E (pt) 2003-12-31
US5691314A (en) 1997-11-25
USRE40119E1 (en) 2008-02-26
ATE249233T1 (de) 2003-09-15
ES2206622T3 (es) 2004-05-16
EP0796622A2 (fr) 1997-09-24
DK0796622T3 (da) 2004-01-12
EP0796622A3 (fr) 1999-02-24
DE69724682D1 (de) 2003-10-16
EP0796622B1 (fr) 2003-09-10

Similar Documents

Publication Publication Date Title
DE69724682T2 (de) Verwendung von Gonadotropin releasing Hormon Analogen oder änlichen Verbindungen zur Herstellung von pharmazeutischen Zubereitungen als Zusatz für invasiver Behandlung von Karzinomen
DE69214818T2 (de) LHRH-Antagonisten
US5003011A (en) Therapeutic decapeptides
McLACHLAN et al. Clinical aspects of LHRH analogues in gynaecology: a review
US5998377A (en) Means for treating prostate cancer
Schulze et al. Influence of different types of antiandrogens on luteinizing hormone-releasing hormone analogue-induced testosterone surge in patients with metastatic carcinoma of the prostate
Stewart et al. Steroidal treatment of myomas: preoperative and long-term medical therapy
DD248365A5 (de) Gnrh-antagonisten vi
US5180711A (en) Combined treatment with gnrh antagonist and gnrh to control gonadotropin levels in mammals
DE60132072T2 (de) Verwendungen zur behandlung von fsh-verbundenen zuständen mit gnrh antagonisten
Erickson et al. GnRH analogues in the treatment of endometriosis
Chodak Luteinizing hormone-releasing hormone (LHRH) agonists for treatment of advanced prostatic carcinoma
US5023234A (en) Combination male breast cancer therapy
US5824286A (en) Mammography method
Gohar et al. GnRH in pregnancy
DE69515666T2 (de) VERWENDUNG VON GnRH-ANTAGONISTEN ZUR HERSTELLUNG EINES MEDIKAMENTS ZUR BEHANDLUNG GONADEN-STEROID ABHÄNGIGER ERKRANKUNGEN
EP0811382B1 (fr) Procédé de mammographie
Akagbosu The use of GnRH agonists and
KR100210472B1 (ko) 황체형성 호르몬 분비 호르몬 길항 펩티드
Fraser LHRH antagonists and female reproductive function
US7235524B2 (en) Medicaments for initiating ovulation
Monroe et al. Clinical investigations of the contraceptive and therapeutic potential of nafarelin
CH678013A5 (fr)
Derman et al. Regulation of pituitary response to gonadotrophin releasing hormone
Grosskinsky et al. Ovulation induction in the anovulatory woman with GnRH agonists

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: EASTERN VIRGINIA MEDICAL SCHOOL, NORFOLK, VA., US

8363 Opposition against the patent
8331 Complete revocation